Control of Treg cell homeostasis and immune equilibrium by Lkb1 in dendritic cells
To balance immunity and tolerance, the endogenous pool of Foxp3 + regulatory T (T reg ) cells is tightly controlled, but the underlying mechanisms of this control remain poorly understood. Here we show that the number of T reg cells is negatively regulated by the kinase Lkb1 in dendritic cells (DCs)...
Saved in:
Published in | Nature communications Vol. 9; no. 1; pp. 1 - 16 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
13.12.2018
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To balance immunity and tolerance, the endogenous pool of Foxp3
+
regulatory T (T
reg
) cells is tightly controlled, but the underlying mechanisms of this control remain poorly understood. Here we show that the number of T
reg
cells is negatively regulated by the kinase Lkb1 in dendritic cells (DCs). Conditional knockout of the
Lkb1
gene in DCs leads to excessive T
reg
cell expansion in multiple organs and dampens antigen-specific T cell immunity. Lkb1-deficient DCs are capable of enhancing, compared with wild-type DCs, T
reg
cell proliferation via cell-cell contact involving the IKK/IKBα-independent activation of the NF-κB/OX40L pathway. Intriguingly, treating wild-type mice with lipopolysaccharide selectively depletes Lkb1 protein in DCs, resulting in T
reg
cell expansion and suppressed inflammatory injury upon subsequent challenge. Loss of Lkb1 does not obviously upregulate proinflammatory molecules expression on DCs. We thus identify Lkb1 as a regulatory switch in DCs for controlling T
reg
cell homeostasis, immune response and tolerance.
Regulatory T (Treg) cells are important for maintaining immune homeostasis by suppressing immune cell activation, but how the Treg cell pool is maintained is still unclear. Here the authors show that a kinase, Lkb1, operates in dendritic cells (DC) to inhibit Treg cell expansion and immunosuppression via mechanisms involving NF-kB/OX40L signalling. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2041-1723 2041-1723 |
DOI: | 10.1038/s41467-018-07545-8 |